What did you have in mind?

Since the quarter report was just released, which is the best time to deliver good news, and the update was pretty vanilla, it's difficult to see anything of significance being released.

I was hoping for a tidbit on the extended battery life, maybe it's not unique enough to provide the market with information for other applications.

If you are thinking share price, the excellent quarter results compared with past quarters didn't result in any price movement, so even new IFE orders announced would probably not impact the price.

Mentioned in a company communication more than a year ago was the possibility of sales to the healthcare industry or other market segments, however the reality of this happening has dwindled over time.    

Based on the general feeling of others on the board, the Vivitar issue may take several more months, so that is well into next fiscal year.

I'm lost as to what news could be on the horizon, especially news good enough to provide a price improvement.

The waiting game is still in place, many months, perhaps a year or two or more.